glioma
Conditions
Interventions
HOXA5 gene amplification group:None
HOXA5 Non-amplified group:None
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Age, gender is not limited; 2) Surgical treatment patients diagnosed with glioma in neurosurgery and pathology department of our hospital; 3) Pathological diagnosis of glioblastoma (WHO grade I-IV); 4) Have complete molecular pathological test results or the biobank of our hospital retains enough samples for molecular pathological test; 5) Complete follow-up data has been obtained or the subjects voluntarily cooperate with follow-up follow-up (they cannot participate in multiple clinical studies).
Exclusion criteria
Exclusion criteria: 1.The histological diagnosis was not clear; 2.Patients with pre-existing physical or mental illnesses that may affect the results of this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HOXA5 gene amplification; | — |
Countries
China
Contacts
Public ContactZhicheng He
The First Affiliated Hospital of Army Medical University
Outcome results
None listed